Evidence map›Paper›PMID 41918329›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026

Expedient Discovery of a Metallaphotoredox Cyanomethylation for Synthesizing α-Aryl Nitriles.

Gemma C Cook, Blandine McKay, Craig Jamieson, Lee J Edwards, Charlotte Harriman, Zackary S Read, Simon T Bate

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gemma C CookMolecular Modalities Capabilities (MMC), GSK Medicines Research Centre, Stevenage, Hertfordshire, UK.
Blandine McKayMolecular Modalities Capabilities (MMC), GSK Medicines Research Centre, Stevenage, Hertfordshire, UK.
Craig JamiesonDepartment of Pure and Applied Chemistry WestCHEM, University of Strathclyde, Glasgow, UK.
Lee J EdwardsDrug Substance Development, Process Engineering & PAT, GSK Medicines Research Centre, Stevenage, Hertfordshire, UK.ORCID https://orcid.org/0000-0002-5645-746X
Charlotte HarrimanMolecular Modalities Capabilities (MMC), GSK Medicines Research Centre, Stevenage, Hertfordshire, UK.
Zackary S ReadCMC Statistics, GSK Medicines Research Centre, Stevenage, Hertfordshire, UK.
Simon T BateCMC Statistics, GSK Medicines Research Centre, Stevenage, Hertfordshire, UK.

Funding

EPSRC EP/S035990/1
6 · The paper itself

Abstract

The α-aryl nitrile motif is a valuable pharmacophoric feature in medicinal chemistry. However, current synthetic methods to prepare this moiety frequently employ harsh reaction conditions, highly toxic cyanide reagents, or have a limited substrate scope. To address this, a mild photocatalytic cyanomethylation reaction was developed, employing an iridium/nickel metallaphotoredox system in conjunction with supersilanol, cyclopropyl bromide and a mild base, and blue light. To identify a robust set of conditions to efficiently couple acetonitrile to a range of aryl bromides, extensive High-Throughput Experimentation (HTE) was first applied. Subsequently, Design-of-Experiments (DoE) scoping and then screening experiments were performed to identify significant factors and interactions. Due to evidence of non-linear effects, this was followed by an optimization experiment using a central composite design. Finally, to confirm the conditions identified, a robustness DoE study was performed. The methodology demonstrated tolerance to a variety of functional groups, and was applicable to a range of medicinally-relevant building blocks through library synthesis. The reaction was also applied to the multigram preparation of a key anti-cancer Senexin intermediate, which shortened the synthetic route and obviated the need for a cyanide reagent.

Indexed as

C‐C couplingcross‐couplingphotocatalysisphotochemistrysynthetic methods

Identifiers

PMID41918329
PMCPMC13282906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.